Suboxone - direct healthcare professional communication (DHPC)

buprenorphine / naloxone

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Suboxone sublingual tablets (buprenorphine / naloxone): inaccurate Braille information on the carton for HU/CZ/SK pack

Dissemination date: 18/06/2020

Key facts

• Medicine name:
  Suboxone
• Active substance:
  • buprenorphine
  • naloxone
• Therapeutic area (MeSH):
  Opioid-Related Disorders
• Procedure number:
  EMEA/H/C/000697
• DHPC type:
  Quality defect
• Human ATC codes:
  N07BC51
• Dissemination date:
  18/06/2020